SPDR S&P Biotech ETF (NYSEARCA:XBI) Shares Sold by GenTrust LLC

GenTrust LLC trimmed its stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 0.1% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 189,392 shares of the exchange traded fund’s stock after selling 178 shares during the quarter. GenTrust LLC owned about 0.25% of SPDR S&P Biotech ETF worth $17,057,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds have also made changes to their positions in the stock. Hartline Investment Corp raised its position in shares of SPDR S&P Biotech ETF by 2.0% during the 3rd quarter. Hartline Investment Corp now owns 5,502 shares of the exchange traded fund’s stock worth $544,000 after purchasing an additional 106 shares during the period. Addison Advisors LLC boosted its stake in SPDR S&P Biotech ETF by 27.4% during the 4th quarter. Addison Advisors LLC now owns 535 shares of the exchange traded fund’s stock valued at $48,000 after purchasing an additional 115 shares in the last quarter. Signature Estate & Investment Advisors LLC boosted its stake in SPDR S&P Biotech ETF by 5.7% during the 3rd quarter. Signature Estate & Investment Advisors LLC now owns 2,336 shares of the exchange traded fund’s stock valued at $231,000 after purchasing an additional 125 shares in the last quarter. Graypoint LLC boosted its stake in SPDR S&P Biotech ETF by 5.6% during the 3rd quarter. Graypoint LLC now owns 2,738 shares of the exchange traded fund’s stock valued at $271,000 after purchasing an additional 146 shares in the last quarter. Finally, Zurcher Kantonalbank Zurich Cantonalbank boosted its stake in SPDR S&P Biotech ETF by 0.6% during the 3rd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 23,873 shares of the exchange traded fund’s stock valued at $2,373,000 after purchasing an additional 148 shares in the last quarter.

SPDR S&P Biotech ETF Stock Performance

Shares of NYSEARCA XBI opened at $88.25 on Thursday. The stock has a fifty day moving average price of $91.11 and a two-hundred day moving average price of $95.87. The firm has a market cap of $5.82 billion, a P/E ratio of 11.47 and a beta of 0.93. SPDR S&P Biotech ETF has a 1 year low of $81.14 and a 1 year high of $105.47.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.